OSCR - Oscar Health, Inc.
NYSE
->
Healthcare
->
Healthcare Plans
New York,
United States
Type: Equity
OSCR price evolution
OSCR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2268.15 | $2230.8 | $1870.32 | |
| Short term investments | $363.64 | $616.13 | $689.83 | |
| Net receivables | $63.51 | $711.79 | $647.88 | $494.39 |
| Inventory | ||||
| Total current assets | $63.51 | $3359.09 | $3503.79 | $3061.1 |
| Long term investments | $1495.83 | $766.44 | $395.18 | |
| Property, plant & equipment | $66.63 | $63.95 | $61.41 | $61.93 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1647.06 | $915.06 | $540.38 | |
| Total investments | $1859.47 | $1382.57 | $1085.01 | |
| Total assets | $4483.02 | $5006.15 | $4418.85 | $3601.48 |
| Current liabilities | ||||
| Accounts payable | $395.48 | $3438.88 | $2949.55 | $2357.32 |
| Deferred revenue | $59.97 | $65.54 | $65.92 | |
| Short long term debt | ||||
| Total current liabilities | $395.48 | $3501.74 | $3019.43 | $2429.01 |
| Long term debt | $299.36 | $299.17 | $298.97 | $298.78 |
| Total noncurrent liabilities | $363.84 | $365.14 | $366.35 | |
| Total debt | $299.17 | $298.97 | $298.78 | |
| Total liabilities | $3320.25 | $3865.58 | $3384.57 | $2795.36 |
| Shareholders' equity | ||||
| Retained earnings | -$2697.74 | -$2643.14 | -$2699.35 | -$2876.72 |
| Other shareholder equity | -$0 | -$2.63 | -$2.59 | $1.31 |
| Total shareholder equity | $1138.2 | $1032.02 | $803.97 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1870.32 | $1558.6 | $1103.99 | $826.33 |
| Short term investments | $689.83 | $1397.29 | $587.09 | $366.39 |
| Net receivables | $494.39 | $49.86 | $611.06 | $675.87 |
| Inventory | ||||
| Total current assets | $3061.1 | $49.86 | $2305.93 | $1870.45 |
| Long term investments | $395.18 | $250.4 | $872.56 | $325.74 |
| Property, plant & equipment | $61.93 | $127.89 | $46.61 | $35.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $540.38 | $405.05 | $1015.72 | $401.66 |
| Total investments | $1085.01 | $1647.69 | $1459.65 | $692.13 |
| Total assets | $3601.48 | $4526.6 | $3321.65 | $2272.11 |
| Current liabilities | ||||
| Accounts payable | $2357.32 | $285.02 | $1748 | $1509.12 |
| Deferred revenue | $65.92 | $79 | $75.04 | $71.9 |
| Short long term debt | ||||
| Total current liabilities | $2429.01 | $370.02 | $1852.29 | $1665.6 |
| Long term debt | $298.78 | $298 | $142.49 | |
| Total noncurrent liabilities | $366.35 | $370.28 | $76.84 | $157.49 |
| Total debt | $298.78 | $298 | $142.49 | |
| Total liabilities | $2795.36 | $3636.22 | $1929.13 | $1823.09 |
| Shareholders' equity | ||||
| Retained earnings | -$2876.72 | -$2605.99 | -$1999.71 | -$1427.11 |
| Other shareholder equity | $1.31 | -$9.71 | -$3.67 | $0.88 |
| Total shareholder equity | $803.97 | $890.38 | $1387.23 | -$1295.89 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2219.34 | $2142.3 | ||
| Cost of revenue | $1708.72 | $1554.77 | ||
| Gross Profit | $510.62 | $587.53 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $435.21 | $394.16 | ||
| Total operating expenses | $442.81 | $401.97 | ||
| Operating income | $67.81 | $185.56 | ||
| Income from continuing operations | ||||
| EBIT | $66.83 | $184.27 | ||
| Income tax expense | $4.64 | $1 | ||
| Interest expense | $5.99 | $5.9 | ||
| Net income | ||||
| Net income | $56.21 | $177.37 | ||
| Income (for common shares) | $56.21 | $177.37 | ||
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5862.87 | $462.8 | ||
| Cost of revenue | $5468.04 | $381.17 | ||
| Gross Profit | $394.83 | $81.63 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $339.72 | $166.66 | ||
| Total operating expenses | $630.44 | $483.9 | ||
| Operating income | -$235.62 | -$402.27 | ||
| Income from continuing operations | ||||
| EBIT | -$242.83 | -$402.27 | ||
| Income tax expense | $3.29 | $1.04 | ||
| Interest expense | $24.6 | $3.51 | ||
| Net income | ||||
| Net income | -$270.73 | -$406.82 | ||
| Income (for common shares) | -$270.73 | -$406.82 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $56.21 | $177.37 | -$150.03 | |
| Operating activities | ||||
| Depreciation | $7.6 | $7.81 | $7.74 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28.71 | $25.95 | $26.14 | |
| Total cash flows from operations | $497.15 | $634.36 | $296.87 | |
| Investing activities | ||||
| Capital expenditures | -$7.56 | -$5.95 | -$6.1 | |
| Investments | -$470.06 | -$294.64 | $178.58 | |
| Total cash flows from investing | -$1355.99 | -$477.63 | -$300.59 | $172.48 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $18.7 | $27.31 | $1.07 | |
| Net borrowings | ||||
| Total cash flows from financing | $64.57 | $18.7 | $27.31 | $1.07 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$660.04 | $38.23 | $361.08 | $470.41 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$270.73 | -$606.27 | -$572.61 | -$406.82 |
| Operating activities | ||||
| Depreciation | $30.69 | $15.28 | $14.61 | $11.29 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $159.68 | $112.33 | $86.3 | $35.87 |
| Total cash flows from operations | -$272.16 | $380.35 | -$181.75 | $222.73 |
| Investing activities | ||||
| Capital expenditures | -$25.58 | -$29.01 | -$25.89 | -$14.02 |
| Investments | $602.76 | -$197.51 | -$748.63 | -$329.45 |
| Total cash flows from investing | $577.19 | -$226.52 | -$774.51 | -$344.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.96 | $1.3 | $1407.1 | $19.3 |
| Net borrowings | $297.96 | -$166.17 | $142.16 | |
| Total cash flows from financing | $6.45 | $301.11 | $1238.71 | $611.71 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $311.47 | $454.94 | $282.45 | $489.73 |
News
Fundamentals
| Market cap | $3.48B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 247.22M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 3.48 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.16 |
| Quick ratio | N/A |